Arteriosclerosis and Thrombosis, Vol 11, 1619-1635, Copyright © 1991 by American Heart Association

ARTICLES

George Lyman Duff Memorial Lecture. Multifactorial etiology of hypercholesterolemia. Implications for prevention of coronary heart disease

SM Grundy
Center for Human Nutrition, University of Texas Southwestern Medical Center, Dallas 75235-9052.

This review underlines the concept that multiple factors are responsible for hypercholesterolemia in the American public. Dietary factors (cholesterol, saturated fatty acids, and obesity) clearly raise the cholesterol level, and they are important causes of borderline-high cholesterol. Still, the unexplained decline of LDL receptor activity with aging contributes importantly to borderline-high levels and cannot be ignored. The loss of estrogen-stimulated LDL receptor synthesis after menopause is an important contributor to elevated cholesterol in postmenopausal women. In addition, several genetic defects inherited singly appear to be responsible for moderate hypercholesterolemia. Some of these defects may represent genetic hypersensitivity to diet, and dietary therapy alone may provide adequate cholesterol lowering. Other defects impart resistance to dietary control, and use of a single cholesterol-lowering drug may be required. With the exception of heterozygous FH, most cases of severe hypercholesterolemia appear to be the result of the coexistence of at least two defects in LDL metabolism, and as a rule, they can be treated successfully only by using cholesterol-lowering drugs in combination.

This article has been cited by other articles:

				L. H. Kuller, L. R. Simkin-Silverman, R. R. Wing, E. N. Meilahn, and D. G. Ives Women's Healthy Lifestyle Project: A Randomized Clinical Trial : Results at 54 Months Circulation, January 2, 2001; 103(1): 32 - 37. [Abstract] [Full Text] [PDF]

				B. M. Wolfe, P. H. R. Barrett, L. Laurier, and M. W. Huff Effects of continuous conjugated estrogen and micronized progesterone therapy upon lipoprotein metabolism in postmenopausal women J. Lipid Res., March 1, 2000; 41(3): 368 - 375. [Abstract] [Full Text]

				G. L. Vega and S. M. Grundy Hypercholesterolemia With Cholesterol-Enriched LDL and Normal Levels of LDL–Apolipoprotein B : Effects of the Step I Diet and Bile Acid Sequestrants on the Cholesterol Content of LDL Arterioscler Thromb Vasc Biol, April 1, 1996; 16(4): 517 - 522. [Abstract] [Full Text]

				C. A. Aguilar-Salinas, P. H. R. Barrett, K. G. Parhofer, S. G. Young, D. Tessereau, J. Bateman, C. Quinn, and G. Schonfeld Apoprotein B-100 Production Is Decreased in Subjects Heterozygous for Truncations of Apoprotein B Arterioscler Thromb Vasc Biol, January 1, 1995; 15(1): 71 - 80. [Abstract] [Full Text]

				M. Farnier, F. Bonnefous, N. Debbas, and A. Irvine Comparative Efficacy and Safety of Micronized Fenofibrate and Simvastatin in Patients With Primary Type Ha or IIb Hyperlipidemia Arch Intern Med, February 28, 1994; 154(4): 441 - 449. [Abstract] [PDF]

				S. Zhang, R. Reddick, J. Piedrahita, and N Maeda Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E Science, October 16, 1992; 258(5081): 468 - 471. [Abstract] [PDF]